Volanesorsen
Volanesorsen
Volanesorsen (pronounced vo-lan-e-sor-sen) is a medication used in the treatment of familial chylomicronemia syndrome (FCS), a rare genetic disorder characterized by the inability to break down fats, leading to high levels of fat in the blood.
Etymology
The name "Volanesorsen" is derived from the drug's mechanism of action. "Volane" is a reference to its ability to "fly" or move through the bloodstream, while "sorsen" is derived from the Latin word "sors", meaning "fate" or "destiny". This reflects the drug's ability to alter the course of the disease.
Mechanism of Action
Volanesorsen works by inhibiting the production of Apolipoprotein C-III (ApoC-III), a protein that regulates the breakdown of fats in the body. By reducing the levels of ApoC-III, Volanesorsen allows for the normal breakdown and removal of fats from the bloodstream.
Related Terms
- Familial chylomicronemia syndrome (FCS): A rare genetic disorder characterized by the inability to break down fats, leading to high levels of fat in the blood.
- Apolipoprotein C-III (ApoC-III): A protein that regulates the breakdown of fats in the body.
- Lipid: A type of fat found in the blood.
- Triglyceride: The main type of fat found in the body, high levels of which can lead to conditions such as heart disease.
See Also
External links
- Medical encyclopedia article on Volanesorsen
- Wikipedia's article - Volanesorsen
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski